Brain inflammation linked to more severe Parkinson's symptoms

August 28, 2013, Michigan State University
Lena Brundin is an associate professor in the college and a researcher with the Van Andel Institute.

Reversing inflammation in the fluid surrounding the brain's cortex may provide a solution to the complex riddle of Parkinson's, according to researchers who have found a link between pro-inflammatory biomarkers and the severity of symptoms such as fatigue, depression and anxiety in patients with the chronic disease.

Lena Brundin of Michigan State University's College of Human Medicine was part of a research team that measured inflammatory markers found in cerebrospinal fluid samples of Parkinson's patients and members of a control group.

"The degree of neuroinflammation was significantly associated with more , fatigue, and cognitive impairment even after controlling for factors such as age, gender and disease duration," said Brundin, an associate professor in the college and a researcher with the Van Andel Institute.

"By investigating associations between inflammatory markers and non-motor symptoms we hope to gain further insight into this area, which in turn could lead to new treatment options."

The results of the study were published in the journal Brain, Behavior, and Immunity.

Inflammation in the brain long has been suspected to be involved in the development of Parkinson's disease, specifically in non-motor symptoms such as depression, fatigue and . Recent research suggests inflammation could drive cell death and that developing that target this inflammation might slow disease progression.

Parkinson´s disease is the second most common of the ; the causes of the disease and its development are not yet fully understood.

"The few previous studies investigating in the cerebrospinal fluid of Parkinson's patients have been conducted on comparatively small numbers of subjects, and often without a healthy control group for comparison," Brundin said.

In the study, 87 Parkinson's patients were enrolled between 2008 and 2012. For the control group, 37 individuals were recruited. Participants underwent a general physical exam and routine blood screening. Researchers looked at the following markers: C-reactive protein, interleukin-6, tumor necrosis factor-alpha, eotaxin, interferon gamma-induced protein-10, monocyte chemotactic protein-1 and macrophage inflammatory protein 1-?.

The study was carried out in collaboration with researchers from Lund University in Sweden, Skåne University Hospital in Sweden and the Mayo Clinic College of Medicine in Florida.

Explore further: Comprehensive Parkinson's biomarker test has prognostic and diagnostic value

Related Stories

Comprehensive Parkinson's biomarker test has prognostic and diagnostic value

August 26, 2013
Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein ...

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer's disease

October 22, 2012
Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer's disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska ...

Countering brain chemical could prevent suicides

December 14, 2012
(Medical Xpress)—Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.

Depression a key factor in health of Parkinson's patients: study

November 28, 2012
(HealthDay)—Depression is the most important determinant of the health status of people with Parkinson's disease, according to early findings from a large study of Parkinson's patients.

Researchers look for clues to progression of Parkinson's disease

July 19, 2013
Emory researchers are conducting a prospective clinical study to examine the possibility of diagnosing Parkinson's disease (PD) before motor symptoms occur. The study is an arm of the Parkinson's Progression Markers Initiative ...

Diabetes drug tested in Parkinson's disease patients

May 20, 2013
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the ...

Recommended for you

A new therapeutic avenue for Parkinson's disease

January 23, 2018
Systemic clearing of senescent astrocytes prevents Parkinson's neuropathology and associated symptoms in a mouse model of sporadic disease, the type implicated in 95% of human cases. Publishing in Cell Reports, researchers ...

Investigators eye new target for treating movement disorders

January 19, 2018
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

Parkinson's disease 'jerking' side effect detected by algorithm

January 8, 2018
A mathematical algorithm that can reliably detect dyskinesia, the side effect from Parkinson's treatment that causes involuntary jerking movements and muscle spasms, could hold the key to improving treatment and for patients ...

New brainstem changes identified in Parkinson's disease

January 4, 2018
A pioneering study has found that patients with Parkinson's disease have more errors in the mitochondrial DNA within the brainstem, leading to increased cell death in that area.

Caffeine level in blood may help diagnose people with Parkinson's disease

January 3, 2018
Testing the level of caffeine in the blood may provide a simple way to aid the diagnosis of Parkinson's disease, according to a study published in the January 3, 2018, online issue of Neurology, the medical journal of the ...

Researchers shed light on why exercise slows progression of Parkinson's disease

December 22, 2017
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.